SMSouheyla Mekraf

Souheyla Mekraf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Souheyla Mekraf has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antioxidant and antimicrobial activities of Lavandula dentata extracts: A comparative study of solvent efficacy

    by Leila Gadouche, Sabrina Riati, Souheyla Mekraf, Seyf Eddine Bahraoui, Khadidja Rekmouche

    Lavandula dentata, commonly known as “el khouzama” in Algeria, is a medicinal plant widely recognized for its aromatic and therapeutic properties. In the context of increasing bacterial resistance to antibiotics and the harmful effects of oxidative stress, the flowers and leaves of L. dentata may offer a promising natural alternative. This work aims to evaluate the antioxidant and antimicrobial effects of ethanolic and aqueous extracts obtained from the aerial parts of L. dentata. Both extracts significantly inhibited DPPH free radicals, with the ethanolic extract showing greater efficiency (IC₅₀ = 0.53 ± 0.06 mg/mL). The aqueous extract reduced ferric iron to ferrous iron to a significantly higher extent (99.21 ± 0.06 mM Fe²⁺/g extract) compared with the ethanolic extract (69.22 ± 0.13 mM Fe²⁺/g extract) (p < 0.05). The ethanolic extract exhibited a total antioxidant capacity of approximately 19.15 ± 0.01 mg Eq AA/g DM, which was higher than that of the aqueous extract (8.64 ± 0.02 mg Eq AA/g DM) (p > 0.05). The evaluation of antimicrobial activity using the agar diffusion method and MIC determination revealed that all seven microbial strains were highly sensitive to the ethanolic extract, which produced inhibition zones ranging from 13 ± 0 to 17 ± 2.45 mm (p < 0.01). The minimum inhibitory concentration (MIC) was 40 ± 0 mg/mL for all strains. The aqueous extract was effective only against E. hirae and C. albicans, producing inhibition zones of 14.67 ± 0.47 mm and 11.33 ± 1.00 mm, respectively, with MIC values of 7.5 ± 4.33 and 8.33 ± 2.89 mg/mL (p > 0.05). Overall, L. dentata demonstrates potent antioxidant and antimicrobial properties, supporting its potential application in the agri-food and pharmaceutical industries.


  • Phenolic profile, in vitro bioactivities, and in silico inhibition of α-amylase and trypsin by Thymelaea hirsuta (L.) Endl.

    by Kamal Nedjari Benhadj Ali, Mohammed Bouzouina, Djilali Benabdelmoumene, Souheyla Mekraf, Mohammed Cheurfa, Abdelaziz Merouane

    Research on plants like Thymelaea hirsuta (L.) Endl. is increasingly crucial for identifying alternative therapies for chronic diseases. This study investigated the n-butanol leaf fraction (NBF) of T. hirsuta for its antioxidant, anti-diabetic, and anti-inflammatory properties through in vitro experiments, including 2,2-diphenyl-1-picrylhydrazyl (DPPH•), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS•+), Ferric Reducing Antioxidant Power (FRAP), Ferrous Ion Chelating (FIC), α-amylase inhibition, and anti-inflammatory assays. In silico study was also conducted against α-amylase and trypsin enzymes. Eighteen (18) compounds, including various phenolic acids and flavonoids, were identified by HPLC-PDA-MS/MS. The NBF demonstrated potent antioxidant activity, exhibiting 99.60% inhibition against ABTS•+, 92.85% against DPPH•, and 88.05% for FIC. It also showed significant α-amylase inhibition (85.40% at 5 mg/mL; IC50: 0.37 ± 0.08 mg/mL). Furthermore, the NBF displayed notable anti-inflammatory activities, with 95.37% inhibition of protein denaturation (IC50: 1.83 ± 0.06 mg/mL), 79.14% inhibition of heat-induced haemolysis (IC50: 0.026 mg/mL), and 77.72% inhibition of proteinase (IC50: 0.81 ± 0.95 mg/mL). In silico molecular docking studies against α-amylase and trypsin enzymes revealed feruloyl apigenin as a promising dual inhibitor. This novel compound exhibited a binding affinity comparable to acarbose and diclofenac sodium. These findings highlight the NBF of T. hirsuta as a potential source of bioactive compounds for future anti-inflammatory and anti-diabetic pharmaceutical development.